<PAGE>
EXHIBIT 23.1
CONSENT OF INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration
Statement (Form S-8) pertaining to the 1996 Stock Option Plan, as amended, of
Salix Pharmaceuticals, Ltd. of our report dated March 9, 2000 with respect to
the financial statements of Salix Pharmaceuticals, Ltd. included in its Annual
Report (Form 10-K405) for the year ended December 31, 1999, filed with the
Securities and Exchange Commission.
/s/ Ernst & Young LLP
Raleigh, North Carolina
October 6, 2000
